drugset / Trial / NCT02483299
Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary Syndrome
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study was to determine whether combined treatment with liraglutide and metformin is more effective than metformin as monotherapy in the treatment of obese women with polycystic ovary syndrome (PCOS). We anticipated greater changes in body weight in patients on combined treatment than in those on monotherapy.
Timeline
- Start
- 2014-01
- Primary completion
- 2015-04
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Liraglutide | Peptide | 1.2 mg | Subcutaneous |
| Comparator | Metformin | Small molecule | 1000 mg | Oral |